Signet Therapeutics
Newton
About Signet Therapeutics
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.6M
- Funding stage: Seed
- Last round: Seed (Jan 2020)
- Website: signetbio.com
Industries & Categories
Biotechnology, Life Science
Canonical: https://fsome.com/organization/signet-therapeutics-74591 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.